Spotlight
Video

Playlist: University of Texas Southwestern Medical Center, Kidney Cancer Program


09:43
Eighth International Kidney Cancer Symposium - Jeffrey Caddedu, M.D. For more in this series: http://www.K.... Disclosure of our financials and corporate sponsors of our website and videos is freely available at http://www.K....
by:kidneycancer | 6341 views
01:25
James Brugarolas, MD of UT Southwestern Medical Center discusses the use of targeted therapies in treating non-clear cell renal cell carcinoma at the 2017 Genitourinary Cancers Symposium (ASCO GU) in Orlando, Florida.
by:obr | 718 views
01:53
James Brugarolas, MD of UT Southwestern Medical Center explains how immunotherapies are being integrated into renal cell carcinoma treatment algorithms at the 2017 Genitourinary Cancers Symposium (ASCO GU) in Orlando, Florida.
by:obr | 589 views
02:17
Dr Hans Hammers (Johns Hopkins, MD) discusses highlights from the Thirteenth International Kidney Cancer Symposium. Immunotherapies have received significant interest: immune checkpoint inhibitors have the potential to durably control disease. Although significant progress has been made in the clear...
by:EMJ | 1432 views
19:12
Timothy A. Masterson, MD Assistant ProfessorDepart​ment of UrologyIndiana University Medical Center and Vitaly Margulis MD Associate Professor of Urology of UT Southern Medical Center debate the Debate: Partial Nephrectomy v. RADICALNephrect​omy for T1b/2a tumors
by:kidneycancer | 768 views
03:08
At the Thirteenth International Kidney Cancer Symposium, Dr Hans Hammers (Johns Hopkins, MD) discusses the Phase 1 clinical trial that studied the immune checkpoint inhibitors, nivolumab and ipilimumab, in metastatic renal cell carcinoma (mRCC). The primary endpoint was to access safety and tolerabi...
by:EMJ | 1111 views
07:35
At the Thirteenth International Kidney Cancer Symposium, Dr James Brugarolas (University of Texas Southwestern Medical Center, TX) discusses the clinical significance of biologically classifying kidney cancer. Advances in genome sequencing methods allowed the identification of a range of mutatio...
by:EMJ | 776 views
04:05
At the Thirteenth International Kidney Cancer Symposium, Dr Hans Hammers (Johns Hopkins, MD) encourages kidney cancer patients to take an active role in health care. Currently, a strategic and patient-tailore​d approach is recommended in kidney cancer management. Dr Hammers discusses how clinical tri...
by:EMJ | 947 views
20:59
Dr. James Brugarolas, M.D., Ph.D. Kidney Cancer Program Leader Associate Professor of Internal Medicine & Developmental Biology University of Texas Southwestern Medical Center discusses RCC Classification at the Kidney Cancer meeting in Chicago
by:kidneycancer | 1887 views
07:25
Hans Hammers MD, PhD of Johns Hopkins presents "Initial Therapy for mRCC: Pro: Immune Checkpoint Inhibitors"​; at the 14th International Kidney Cancer Symposium.
by:kidneycancer | 563 views
Playlist: University of Texas Southwestern Medical Center, Kidney Cancer Program
Description: Videos from UT Southwestern Kidney Cancer Program researchers and physicians.
From: University of Texas Southwestern Medical Center, Kidney Cancer Program
Videos: 24
More playlists from University of Texas Southwes...

Playlist URL:
Embed: Embed Code Options